Jeffrey Low, MD is a life sciences and healthcare venture capital investor based in the San Francisco Bay Area.

​

Jeffrey is a Partner at Bedford Bridge, bringing nearly a decade of venture capital experience investing in early and growth-stage companies at the intersection of life sciences, healthcare, and technology. He was previously a Principal at Novo Holdings and a Partner at Andreessen Horowitz. Jeffrey has also served as a Scout for Sequoia Capital and held roles at Google Capital (now CapitalG) and Novartis Venture Fund earlier in his career.

​

Throughout his career, he's partnered with more than 30 companies across biotech, life sciences, and healthcare. He's invested broadly in AI including applications in drug discovery, clinical care, early cancer detection, life sciences software, genomics, real world data, and healthcare payments.

​

Jeffrey received an MD from Yale School of Medicine, an MBA from Harvard Business School, and an AB in Molecular and Cellular Biology from Harvard. His work has been recognized on the Forbes 30 under 30 list for Venture Capital,

He is a third generation San Franciscan and an avid squash player. 

​